Header Logo

Connection

Andrew Avins to Tissue Plasminogen Activator

This is a "connection" page, showing publications Andrew Avins has written about Tissue Plasminogen Activator.
Connection Strength

0.468
  1. Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment. Stroke. 2020 09; 51(9):2697-2704.
    View in: PubMed
    Score: 0.181
  2. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System. Stroke. 2018 01; 49(1):133-139.
    View in: PubMed
    Score: 0.151
  3. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy. Arch Intern Med. 1992 Aug; 152(8):1665-72.
    View in: PubMed
    Score: 0.104
  4. Bayesian analysis and the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator in Occluded Arteries. JAMA. 1995 Sep 20; 274(11):873; author reply 874.
    View in: PubMed
    Score: 0.032

© 2024 Kaiser Permanente